Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Histone modifications: implications in renal cell carcinoma.

Ramakrishnan S, Ellis L, Pili R.

Epigenomics. 2013 Aug;5(4):453-62. doi: 10.2217/epi.13.40.

2.

Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.

Morrissey C, Martinez A, Zatyka M, Agathanggelou A, Honorio S, Astuti D, Morgan NV, Moch H, Richards FM, Kishida T, Yao M, Schraml P, Latif F, Maher ER.

Cancer Res. 2001 Oct 1;61(19):7277-81.

3.

Genetic and epigenetic alterations during renal carcinogenesis.

Arai E, Kanai Y.

Int J Clin Exp Pathol. 2010 Dec 13;4(1):58-73. Review.

4.

Unique molecular alteration patterns in von Hippel-Lindau (VHL) gene in a cohort of sporadic renal cell carcinoma patients from Pakistan.

Khaliq S, Ajaz S, Firasat S, Shahid S, Hasan AS, Sultan G, Mohsin R, Hashmi A, Mubarak M, Naqvi SA, Rizvi SA, Mehdi SQ, Abid A.

Mutat Res. 2014 May-Jun;763-764:45-52. doi: 10.1016/j.mrfmmm.2014.03.008. Epub 2014 Apr 12.

PMID:
24727139
6.

[Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].

Rao Q, Zhou J, Zhang RS, Ma HH, Zhou HB, Lu ZF, Zhou XJ.

Zhonghua Bing Li Xue Za Zhi. 2010 Sep;39(9):582-6. Chinese.

PMID:
21092583
7.

[Genetic backgrounds of renal cell carcinoma].

Oya M.

Nihon Rinsho. 2006 Feb;64 Suppl 2:593-6. Review. Japanese. No abstract available.

PMID:
16523961
8.

[Alteration of VHL gene in patients with metastatic renal cell carcinoma].

Peters MV, Matveev VB, Volkova MI, Kalinin SA, Mikhaĭlenko DM.

Urologiia. 2012 May-Jun;(3):22-7. Russian.

PMID:
23074928
9.

The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.

Niu X, Zhang T, Liao L, Zhou L, Lindner DJ, Zhou M, Rini B, Yan Q, Yang H.

Oncogene. 2012 Feb 9;31(6):776-86. doi: 10.1038/onc.2011.266. Epub 2011 Jul 4.

10.

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

Linehan WM, Vasselli J, Srinivasan R, Walther MM, Merino M, Choyke P, Vocke C, Schmidt L, Isaacs JS, Glenn G, Toro J, Zbar B, Bottaro D, Neckers L.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6282S-9S. Review.

11.

Inactivation of BHD in sporadic renal tumors.

Khoo SK, Kahnoski K, Sugimura J, Petillo D, Chen J, Shockley K, Ludlow J, Knapp R, Giraud S, Richard S, Nordenskjöld M, Teh BT.

Cancer Res. 2003 Aug 1;63(15):4583-7.

12.

Epigenetic regulation in RCC: opportunities for therapeutic intervention?

Larkin J, Goh XY, Vetter M, Pickering L, Swanton C.

Nat Rev Urol. 2012 Jan 17;9(3):147-55. doi: 10.1038/nrurol.2011.236. Review.

PMID:
22249190
13.

Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.

Petersson F, Gatalica Z, Grossmann P, Perez Montiel MD, Alvarado Cabrero I, Bulimbasic S, Swatek A, Straka L, Tichy T, Hora M, Kuroda N, Legendre B, Michal M, Hes O.

Virchows Arch. 2010 Apr;456(4):355-65. doi: 10.1007/s00428-010-0898-4. Epub 2010 Mar 19.

PMID:
20300772
14.

The Clinicopathological Significance of Epigenetic Silencing of VHL Promoter and Renal Cell Carcinoma: A Meta-Analysis.

Yang L, Zhao Z, Zhao S, Chen C, Cong X, Li Z, Ren M.

Cell Physiol Biochem. 2016;40(6):1465-1472. doi: 10.1159/000453198. Epub 2016 Dec 20.

15.

[Molecular genetic mechanism of the kidney cancer].

Nakaigawa N, Yao M, Kishida T, Kubota Y.

Nihon Rinsho. 2001 Jan;59(1):104-9. Review. Japanese.

PMID:
11197838
16.

Expression of HGF/SF and Met protein is associated with genetic alterations of VHL gene in primary renal cell carcinomas.

Oh RR, Park JY, Lee JH, Shin MS, Kim HS, Lee SK, Kim YS, Lee SH, Lee SN, Yang YM, Yoo NJ, Lee JY, Park WS.

APMIS. 2002 Mar;110(3):229-38.

PMID:
12076276
17.
18.

The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells.

Koochekpour S, Jeffers M, Wang PH, Gong C, Taylor GA, Roessler LM, Stearman R, Vasselli JR, Stetler-Stevenson WG, Kaelin WG Jr, Linehan WM, Klausner RD, Gnarra JR, Vande Woude GF.

Mol Cell Biol. 1999 Sep;19(9):5902-12.

19.

Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters.

Kondo K, Yao M, Yoshida M, Kishida T, Shuin T, Miura T, Moriyama M, Kobayashi K, Sakai N, Kaneko S, Kawakami S, Baba M, Nakaigawa N, Nagashima Y, Nakatani Y, Hosaka M.

Genes Chromosomes Cancer. 2002 May;34(1):58-68.

PMID:
11921283
20.

Supplemental Content

Support Center